Sutro Biopharma, Inc.
STRO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001382101
No open-market purchases or sales by Sutro Biopharma, Inc. insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $545.7M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Sutro Biopharma, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 123 | 1 | 113 | −9 |
| Shares | 63.9M | 1.32M | 61.5M | −1.11M (−1.8%) |
| Value | $117.6M | $2.44M | $40.0M | −$75.1M (−65.3%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Sutro Biopharma, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 4,434,637 | $2.89M | 0.05% |
| Affinity Asset Advisors, LLC | 752,722 | $489.7K | 0.08% |
| Nuveen, LLC | 290,897 | $189.3K | 0.00% |
| Tang Capital Management LLC | 200,000 | $130.1K | 0.01% |
| State of Wyoming | 94,932 | $61.8K | 0.01% |
| Ieq Capital, LLC | 75,066 | $48.8K | 0.00% |
| Cerity Partners LLC | 39,065 | $25.4K | 0.00% |
| HRT Financial LP | 26,778 | $17.0K | 0.00% |
| Resources Investment Advisors, LLC. | 24,099 | $15.7K | 0.00% |
| Oxford Asset Management LLP | 22,850 | $14.9K | 0.01% |
| CIBC World Markets Corp | 18,164 | $11.8K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 17,199 | $11.2K | 0.00% |
| Prime Capital Investment Advisors, LLC | 17,111 | $11.1K | 0.00% |
| Zacks Investment Management | 15,143 | $9.85K | 0.00% |
| Axxcess Wealth Management, LLC | 12,907 | $8.40K | 0.00% |
| UMA Financial Services, Inc. | 1,304 | $849 | 0.00% |
| Accredited Wealth Management, LLC | 1,000 | $651 | 0.00% |
| Rothschild Investment LLC | 300 | $195 | 0.00% |
Sold out (27)
Institutions that held Sutro Biopharma, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (1)
Institutions that held Sutro Biopharma, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 1,323,777 | $2.44M |